Diagnostics firm Epic Sciences has appointed Greg Lucier as chairman of its board of directors. Lucier, formerly chairman and CEO of Life Technologies, will provide guidance to Epic Sciences in its efforts to commercialize a circulating rare cell analysis platform and other circulating tumor cell-focused products and services.
Peter Dansky, formerly the president of the molecular and cell biology division at Life Technologies, has joined Agena Bioscience as its CEO and a member of its board of directors. He will lead Agena's expansion of its genetic analysis business into new application areas including clinical diagnostics. Previously, he held management positions at Arcturus Bioscience, Affymetrix, Molecular Dynamics, PerSeptive BioSystems, and Millipore.
MolecularHealth has added three new members to its US sales team: Matt Brunner, Bruce Mrachek, and Lee Stuart. Brunner will be regional VP for the western region of the US, while Mrachek and Stuart will serve as senior account directors for the southwest and southeast reagions, respectively.
All three are former employees of Life Technologies and bring with them years of experience in pharmaceutical and diagnostics sales. According to MolecularHealth, the company is expanding its sales team in response to increasing demand for its TreatmentMap cancer therapy decision support offering, launched in April.